Prescription of Glucagon-Like Peptide 1 (GLP-1) in the treatment of patients with type 2 diabetes and obesity: a literature review. (2022). Revista Eletrônica Acervo Médico, 11, e10289. https://doi.org/10.25248/reamed.e10289.2022